East Asia

The manager of Novo Nordisk Foundation’s $36bn of investments is expanding its planetary health portfolio and mulling carving out an allocation for private equity GPs to run, according to partner Aleks Engel.

The $1.8trn pension saw its PE portfolio grow by around $1.4bn year-on-year, per its latest annual report.

China’s private equity reset could yield a more disciplined opportunity set for LPs who retain conviction in the market.

M&A transactions may see a short-term boost this year ahead of tax changes in 2027.

An early-stage SMA is serving as proof of concept for a dedicated strategy in the region, newly appointed APAC co-heads Hari Gopalakrishnan and Nicholas Macksey tell PEI.

Year-on-year growth is back on track after last year’s fundraising flatline, though the nature of this growth has shifted.

The number of regional firms continued to slide in the latest ranking, albeit at a slower rate than in prior years.

In today's edition, How to get the most out of your IR department; Japan's top PE investor enjoys record realisations; A European GP seeks to raise its largest fund yet.

'Chances of us going to market are improving,' says managing partner and head of Southeast Asia Thomas Lanyi.

Advantage’s ambitious plan coincides with the sale of a 5% equity stake to Australia’s Pinnacle Investment Management in January.